112 related articles for article (PubMed ID: 9973468)
21. Diagnosis of Parietaria judaica pollen allergy using natural and recombinant Par j 1 and Par j 2 allergens.
González-Rioja R; Ferrer A; Arilla MC; Ibarrola I; Viguera AR; Andreu C; Martínez A; Asturias JA
Clin Exp Allergy; 2007 Feb; 37(2):243-50. PubMed ID: 17250697
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of sensitization to Artemisia allergens Art v 1, Art v 3 and Art v 60 kDa. Cross-reactivity among Art v 3 and other relevant lipid-transfer protein allergens.
Lombardero M; García-Sellés FJ; Polo F; Jimeno L; Chamorro MJ; García-Casado G; Sánchez-Monge R; Díaz-Perales A; Salcedo G; Barber D
Clin Exp Allergy; 2004 Sep; 34(9):1415-21. PubMed ID: 15347375
[TBL] [Abstract][Full Text] [Related]
23. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens.
Hirahara K; Tatsuta T; Takatori T; Ohtsuki M; Kirinaka H; Kawaguchi J; Serizawa N; Taniguchi Y; Saito S; Sakaguchi M; Inouye S; Shiraishi A
J Allergy Clin Immunol; 2001 Jul; 108(1):94-100. PubMed ID: 11447388
[TBL] [Abstract][Full Text] [Related]
24. The inhibitory effect of altered collagen II peptide on HLA-DRB1-restricted T-cell activation.
Cheng YJ; Zhou Q; Li ZG
Scand J Immunol; 2005 Mar; 61(3):260-5. PubMed ID: 15787743
[TBL] [Abstract][Full Text] [Related]
25. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
Clin Exp Allergy; 2005 May; 35(5):664-71. PubMed ID: 15898991
[TBL] [Abstract][Full Text] [Related]
26. HER-2 peptides p776 and F7, N-terminal-linked with Ii-Key tetramer (LRMK) help the proliferation of E75-TCR+ cells: The dependency of help on the side chains of LRMK-extended peptide pointed towards the T cell receptor.
Li Y; Ishiyama S; Matsueda S; Tsuda N; Ioannides CG
Oncol Rep; 2008 Jun; 19(6):1445-52. PubMed ID: 18497949
[TBL] [Abstract][Full Text] [Related]
27. Assignment of disulphide bridges in Par j 2.0101, a major allergen of Parietaria judaica pollen.
Amoresano A; Pucci P; Duro G; Colombo P; Costa MA; Izzo V; Lamba D; Geraci D
Biol Chem; 2003 Aug; 384(8):1165-72. PubMed ID: 12974385
[TBL] [Abstract][Full Text] [Related]
28. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
29. Emerging principles for the design of promiscuous HLA-DR-restricted peptides: an example from the major bee venom allergen.
Texier C; Pouvelle-Moratille S; Buhot C; Castelli FA; Pecquet C; Ménez A; Leynadier F; Maillère B
Eur J Immunol; 2002 Dec; 32(12):3699-707. PubMed ID: 12516563
[TBL] [Abstract][Full Text] [Related]
30. DNA vaccine using invariant chain gene for delivery of CD4+ T cell epitope peptide derived from Japanese cedar pollen allergen inhibits allergen-specific IgE response.
Toda M; Kasai M; Hosokawa H; Nakano N; Taniguchi Y; Inouye S; Kaminogawa S; Takemori T; Sakaguchi M
Eur J Immunol; 2002 Jun; 32(6):1631-9. PubMed ID: 12115646
[TBL] [Abstract][Full Text] [Related]
31. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy.
Padovan E; Bauer T; Tongio MM; Kalbacher H; Weltzien HU
Eur J Immunol; 1997 Jun; 27(6):1303-7. PubMed ID: 9209477
[TBL] [Abstract][Full Text] [Related]
32. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of binding capacities between HLA class II molecules and synthetic peptides HA307-319].
Ikeda K; Katagiri M
Hokkaido Igaku Zasshi; 1993 May; 68(3):318-24. PubMed ID: 8319931
[TBL] [Abstract][Full Text] [Related]
34. The immunodominant epitope of lipocalin allergen Bos d 2 is suboptimal for human T cells.
Kinnunen T; Buhot C; Närvänen A; Rytkönen-Nissinen M; Saarelainen S; Pouvelle-Moratille S; Rautiainen J; Taivainen A; Maillère B; Mäntyjärvi R; Virtanen T
Eur J Immunol; 2003 Jun; 33(6):1717-26. PubMed ID: 12778490
[TBL] [Abstract][Full Text] [Related]
35. Design of protease-resistant myelin basic protein-derived peptides by cleavage site directed amino acid substitutions.
Burster T; Marin-Esteban V; Boehm BO; Dunn S; Rotzschke O; Falk K; Weber E; Verhelst SH; Kalbacher H; Driessen C
Biochem Pharmacol; 2007 Nov; 74(10):1514-23. PubMed ID: 17803968
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides.
Li X; Li R; Li Z
Tissue Antigens; 2006 Jan; 67(1):45-52. PubMed ID: 16451200
[TBL] [Abstract][Full Text] [Related]
37. Identification of peptides containing T-cell epitopes of Japanese cedar (Cryptomeria japonica) pollen allergen (Cry j 1) in dogs.
Masuda K; Sakaguchi M; Saito S; Yasueda H; Iwabuchi S; Tsukui T; Hayashi N; Nakao Y; Kurata K; Maeda S; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2004 Nov; 102(1-2):45-52. PubMed ID: 15451614
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal digestion of Bet v 1-homologous food allergens destroys their mediator-releasing, but not T cell-activating, capacity.
Schimek EM; Zwölfer B; Briza P; Jahn-Schmid B; Vogel L; Vieths S; Ebner C; Bohle B
J Allergy Clin Immunol; 2005 Dec; 116(6):1327-33. PubMed ID: 16337467
[TBL] [Abstract][Full Text] [Related]
39. Role of APC in the selection of immunodominant T cell epitopes.
Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
[TBL] [Abstract][Full Text] [Related]
40. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]